Zhimeng Yao

1.0k total citations
26 papers, 741 citations indexed

About

Zhimeng Yao is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Zhimeng Yao has authored 26 papers receiving a total of 741 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 11 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in Zhimeng Yao's work include Protein Tyrosine Phosphatases (6 papers), Extracellular vesicles in disease (5 papers) and MicroRNA in disease regulation (5 papers). Zhimeng Yao is often cited by papers focused on Protein Tyrosine Phosphatases (6 papers), Extracellular vesicles in disease (5 papers) and MicroRNA in disease regulation (5 papers). Zhimeng Yao collaborates with scholars based in China, United States and Netherlands. Zhimeng Yao's co-authors include Hao Zhang, Xiao Xiong, Lu Wang, Dianzheng Zhang, Shujun Li, Yuping Chen, Wei Bian, Baoen Shan, Yusheng Lin and Zhirong Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Oncogene and Scientific Reports.

In The Last Decade

Zhimeng Yao

25 papers receiving 738 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhimeng Yao China	14	578	303	132	131	83	26	741
Chiuan‐Ren Yeh United States	16	340 0.6×	207 0.7×	218 1.7×	126 1.0×	185 2.2×	21	819
Aihua Sui China	14	310 0.5×	171 0.6×	87 0.7×	56 0.4×	41 0.5×	38	491
Min Pan China	12	334 0.6×	153 0.5×	213 1.6×	85 0.6×	61 0.7×	35	613
Xiaolei Shi China	11	502 0.9×	317 1.0×	100 0.8×	103 0.8×	54 0.7×	14	802
Ju Hye Shin South Korea	11	269 0.5×	138 0.5×	103 0.8×	62 0.5×	143 1.7×	22	515
Jinsong Wang China	13	387 0.7×	239 0.8×	120 0.9×	62 0.5×	93 1.1×	29	550
Tania L. Slatter New Zealand	21	435 0.8×	176 0.6×	269 2.0×	80 0.6×	106 1.3×	47	801
A‐Bin You China	14	780 1.3×	444 1.5×	136 1.0×	217 1.7×	53 0.6×	17	974
Gang‐Ming Zou China	15	537 0.9×	276 0.9×	140 1.1×	115 0.9×	46 0.6×	27	820

Countries citing papers authored by Zhimeng Yao

Since Specialization

Citations

This map shows the geographic impact of Zhimeng Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhimeng Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhimeng Yao more than expected).

Fields of papers citing papers by Zhimeng Yao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhimeng Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhimeng Yao. The network helps show where Zhimeng Yao may publish in the future.

Co-authorship network of co-authors of Zhimeng Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Zhimeng Yao. A scholar is included among the top collaborators of Zhimeng Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhimeng Yao. Zhimeng Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Xinfeng, Chunguang Li, Zhimeng Yao, et al.. (2025). Zeolite and silica fume as enhancers for cementitious solidification of borate radioactive waste. Nuclear Engineering and Technology. 57(9). 103609–103609. 1 indexed citations

Xiong, Xiao, Jingfang Liu, Xiaotong Wu, et al.. (2025). PTPRO represses breast cancer lung metastasis by inhibiting the JAK2-YAP axis. Scientific Reports. 15(1). 7065–7065.

Wang, Lu, Yu‐Sheng Lin, Zhimeng Yao, et al.. (2024). Targeting undruggable phosphatase overcomes trastuzumab resistance by inhibiting multi-oncogenic kinases. Drug Resistance Updates. 76. 101118–101118. 5 indexed citations

Yao, Zhimeng, et al.. (2024). Extracellular vesicles-based vaccines: Emerging immunotherapies against cancer. Journal of Controlled Release. 378. 438–459. 18 indexed citations

Yao, Zhimeng, et al.. (2023). Peridynamic modeling of hydrogen-assisted white etching cracks in bearing steel under rolling contact fatigue. International Journal of Fatigue. 173. 107698–107698. 3 indexed citations

Dong, Hongmei, Wan‐Wan Lin, Zhimeng Yao, et al.. (2023). PTPRO suppresses lymph node metastasis of esophageal carcinoma by dephosphorylating MET. Cancer Letters. 567. 216283–216283. 7 indexed citations

Wang, Lu, Jinghua Pan, Zhimeng Yao, et al.. (2022). Targeting PELP1 Attenuates Angiogenesis and Enhances Chemotherapy Efficiency in Colorectal Cancer. Cancers. 14(2). 383–383. 6 indexed citations

Dong, Hongmei, Zhimeng Yao, Yusheng Lin, et al.. (2022). PTPRO-related CD8+ T-cell signatures predict prognosis and immunotherapy response in patients with breast cancer. Frontiers in Immunology. 13. 947841–947841. 16 indexed citations

Dong, Hongmei, Wan‐Wan Lin, Chaoying Chen, et al.. (2022). Tyrosine Phosphatase PTPRO Deficiency in ERBB2-Positive Breast Cancer Contributes to Poor Prognosis and Lapatinib Resistance. Frontiers in Pharmacology. 13. 838171–838171. 7 indexed citations

10.

Wang, Lu, Xiao Xiong, Yusheng Lin, et al.. (2021). Repurposing dextromethorphan and metformin for treating nicotine-induced cancer by directly targeting CHRNA7 to inhibit JAK2/STAT3/SOX2 signaling. Oncogene. 40(11). 1974–1987. 30 indexed citations

11.

Wang, Lu, Liang Du, Xiao Xiong, et al.. (2021). Correction: Repurposing dextromethorphan and metformin for treating nicotine-induced cancer by directly targeting CHRNA7 to inhibit JAK2/STAT3/SOX2 signaling. Oncogene. 40(34). 5356–5356. 1 indexed citations

12.

Wang, Lu, Xiao Xiong, Zhimeng Yao, et al.. (2020). Chimeric RNA ASTN2-PAPPAas aggravates tumor progression and metastasis in human esophageal cancer. Cancer Letters. 501. 1–11. 20 indexed citations

13.

Lin, Wan‐Wan, Raju Vivek, Chandrababu Rejeeth, et al.. (2019). Targeted and Intrinsic Activity of HA-Functionalized PEI-Nanoceria as a Nano Reactor in Potential Triple-Negative Breast Cancer Treatment. ACS Applied Bio Materials. 3(1). 186–196. 14 indexed citations

14.

Wang, Lu, Kai Li, Zhimeng Yao, et al.. (2019). Metformin induces human esophageal carcinoma cell pyroptosis by targeting the miR-497/PELP1 axis. Cancer Letters. 450. 22–31. 188 indexed citations

15.

Lin, Yusheng, Xiao Xiong, Kai Li, et al.. (2019). Detection of Exosomal PD-L1 RNA in Saliva of Patients With Periodontitis. Frontiers in Genetics. 10. 202–202. 75 indexed citations

16.

Wang, Lu, Jinfeng Gan, Zhimeng Yao, et al.. (2019). MTA3 Represses Cancer Stemness by Targeting the SOX2OT/SOX2 Axis. iScience. 22. 353–368. 19 indexed citations

17.

Yao, Zhimeng, Min Xu, Kai Li, et al.. (2019). MTA3-SOX2 Module Regulates Cancer Stemness and Contributes to Clinical Outcomes of Tongue Carcinoma. Frontiers in Oncology. 9. 816–816. 14 indexed citations

18.

Li, Zhirong, Xuebo Qin, Wei Bian, et al.. (2019). Exosomal lncRNA ZFAS1 regulates esophageal squamous cell carcinoma cell proliferation, invasion, migration and apoptosis via microRNA-124/STAT3 axis. Journal of Experimental & Clinical Cancer Research. 38(1). 477–477. 143 indexed citations

19.

Wang, Lu, Kai Li, Yi Guo, et al.. (2018). The oncogenic roles of nuclear receptor coactivator 1 in human esophageal carcinoma. Cancer Medicine. 7(10). 5205–5216. 11 indexed citations

20.

Ma, Lang, et al.. (2016). The Many Faces of MTA3 Protein in Normal Development and Cancers. Current Protein and Peptide Science. 17(8). 726–734. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact